FDA DEVICE FACTS
Revaclear 500, Revaclear 400, Revaclear 300
Baxter Healthcare Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The capillary dialyzer/filter is intended for use in hemodialysis, hemodiafiltration and hemofiltration for the treatment of chronic or acute renal failure. Revaclear 400 is indicated for treatment of chronic and acute renal failure by Hemodialysis. Theranova 500 dialyzer is indicated for treatment of chronic kidney failure by intermittent hemodialysis. Revaclear devices are indicated for the treatment of chronic or acute renal failure.. Sterile Yes Yes Yes Same Non- Pyrogenic Yes Yes Yes Same Single Use Yes Yes Yes Same Revaclear 500, 400, 300 Hemodialyzers/Diafilters Features
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。